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Abstract
Background: Coding region microsatellite instability (MSI) results in loss of gene products and promotion of microsatellite-
unstable (MSI-H) carcinogenesis. Recent studies have indicated that MSI within 39-untranslated regions (39UTRs) may post-
transcriptionally dysregulate gene products. Within this context, we conducted a broad mutational survey of 42 short 39UTR
microsatellites (MSs) in 45 MSI-H colorectal tumors and their corresponding normal colonic mucosae.
Methodology/Principal Findings: In order to estimate the overall susceptibility of MSs to MSI in MSI-H tumors, the
observed MSI frequency of each MS was correlated with its length, interspecies sequence conservation level, and distance
from some genetic elements (i.e., stop codon, polyA signal, and microRNA binding sites). All MSs were stable in normal
colonic mucosae. The MSI frequency at each MS in MSI-H tumors was independent of sequence conservation level and
distance from other genetic elements. In contrast, MS length correlated significantly with MSI frequency in MSI-H tumors
(r=0.86, p=7.2610
213). 39UTR MSs demonstrated MSI frequencies in MSI-H tumors higher than the 99% upper limit
predicted by MS length for RB1-inducible coiled-coil 1(RB1CC1, mutation frequency 68.4%), NUAK family SNF1-like kinase
1(NUAK1, 31.0%), and Rtf1, Paf1/RNA polymerase II complex component, homolog (RTF1, 25.0%). An in silico prediction of RNA
structure alterations was conducted for these MSI events to gauge their likelihood of affecting post-transcriptional
regulation. RB1CC1 mutant was predicted to lose a microRNA-accessible loop structure at a putative binding site for the
tumor-suppressive microRNA, miR-138. In contrast, the predicted 39UTR structural change was minimal for NUAK1- and RTF1
mutants. Notably, real-time quantitative RT-PCR analysis revealed significant RB1CC1 mRNA overexpression vs. normal
colonic mucosae in MSI-H cancers manifesting RB1CC1 39UTR MSI (9.0-fold; p=3.6610
24).
Conclusions: This mutational survey of well-characterized short 39UTR MSs confirms that MSI incidence in MSI-H colorectal
tumors correlates with MS length, but not with sequence conservation level or distance from other genetic elements. This
study also identifies RB1CC1 as a novel target of frequent mutation and aberrant upregulation in MSI-H colorectal tumors.
The predicted loss of a microRNA-accessible structure in mutant RB1CC1 RNA fits the hypothesis that 39UTR MSI involves in
aberrant RB1CC1 posttranscriptional upregulation. Further direct assessments are indicated to investigate this possibility.
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Introduction
High-level microsatellite instability (MSI-H) is the molecular
hallmark of a subset of colorectal cancers (CRCs) which carry
defects in DNA mismatch repair (MMR). MSI is defined as
nucleotide length abnormalities occurring within short DNA
sequences consisting of iterated oligonucleotide units (microsatel-
lites), and is widespread throughout the genomes of MSI-H CRC.
MSI exerts its tumorigenic effects when it occurs within protein
coding regions thereby disabling tumor suppressor genes in MSI-H
CRCs via frameshift mutation [1]. The genome-wide distributions
of these coding MSI events have been studied extensively in
different tumor types by several groups, including our own [2,3,4].
MSI also occurs within the 39-untranslated regions (39UTRs) of
genes. Recent advances in RNA research have revealed that the
39UTR plays a prominent role in regulating the stability,
subcellular localization, and translation of its parent mRNA via
sequence-specific interactions with trans-acting factors including
small RNAs and proteins [5]. Mutations within the 39UTR can
affect gene activity if they alter RNA sequence or structure
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7715relevant to these interactions. Several 39UTR point mutations
have been linked to the risk of developing cancer in humans
[6,7,8]. Recent reports have also shown that deleterious mutations
at two 39UTR 8-mer mononucleotide repeats destabilize the
mRNAs in which these mutations occur [9,10]. Taken together,
39UTR MSI events are likely to be important in defining MSI-H
cancer phenotypes, analogous to coding region MSI events.
However, in contrast to coding region MSI, information on
39UTR MSI in MSI-H cancers is limited.
One challenge inherent in MSI profiling is to discriminate
mutations that contribute to carcinogenesis from innocuous
‘‘bystander’’ or ‘‘passenger’’ mutations [11]. A study of long (15-
to 32-mer) 39UTR mononucleotide repeats revealed that these loci
are sometimes polymorphic in MMR-proficient cells, but almost
always unstable in MMR-deficient cells [12]. Thus, we expect that
profiling shorter microsatellites would be more fruitful in identifying
MSIs that were functionally relevant to MSI-H carcinogenesis.
In the current study, we performed broad mutational profiling
of 42 short 39UTR microsatellites (8–14 bases in length) in 45
primary MSI-H colorectal tumors. We also assessed the
correlation between MSI prevalence and microsatellite attributes,
as well as the impact of MSI upon RNA secondary structure. We
utilized the results of these assessments as the basis to discriminate
carcinogenic MSI from likely passenger MSI exerting no beneficial
effect upon tumor cell survival.
Materials and Methods
Identification, enrollment, and annotation of 39UTR
microsatellite loci
39UTR mononucleotide repeats were identified during our
previous genome-wide coding microsatellite search [2]. In this
genome-wide search, 44 loci were initially erroneously classified as
coding region loci by UniGene, but ultimately reclassified correctly
as 39UTR loci after our own individual inspection. In the current
study, 42 of these 44 39UTR mononucleotide repeats (8–14 bases)
were enrolled without regard to their putative functions (two loci
were dropped because of unsuccessful establishment of microsat-
ellite-specific PCR assays). The nucleotide positions of flanking
polyA sites and predicted microRNA (miR) binding sites, along
with the PhastCons basewise conservation score (0 to 1, 1 for
nucleotides in the most conserved sequence contexts among 31
placental mammals) for each microsatellite, were obtained from
the PolyA_DB table under poly(A) track, the TargetScan table
under TS miR sites track, and PhastCons44Placental table under
Conservation track, respectively, within the UCSC Table Browser
[13,14,15,16]. Data on AU-rich elements (ARE) were obtained
from the Integrated ARED database [17]. Putative miR binding
sites were listed only when their presence was also supported by an
independent algorithm, miRanda [18]. Descriptive data for each
microsatellite are shown in Table S1.
Patients and sample DNA preparation
We obtained 44 MSI-H CRCs (nine HNPCC-associated and 35
sporadic), one MSI-H colon adenoma (HNPCC), and their
corresponding normal colonic mucosal tissues from patients who
underwent surgery at the Royal Brisbane Hospital Foundation
Clinical Research Center. Two of the nine HNPCC-associated
CRCs originated from a single patient in a synchronous manner.
Patient enrollment and subsequent study were conducted according
to protocols approved by the Institutional Review Board at Johns
Hopkins University and the Royal Brisbane Hospital Foundation.
Written informed consent was obtained from all patients. Genomic
DNA was extracted from tissues that had been snap-frozen after
mucosal layer enrichment by macroscopic dissection. The MSI-H
status of each tumor was validated by the presence of MSI at two or
more of five consensus loci (BAT25, BAT26, D2S123, D5S346 and
D17S250) [19]. Descriptive data for each tumor are shown in
Table 1. The significantly younger age of HNPCC patients relative
to sporadic cases is consistent with the young-onset nature of the
condition [19].
PCR fragment length polymorphism analysis
PCR fragment length polymorphism analysis was used for MSI
status assessment, as described previously [2]. PCR primer
sequences are listed in Table S1. Instability at each locus was
measured by two variables: %MSI and mean shift. %MSI
represented the prevalence of specimens demonstrating MSI in
all informative specimens at each locus. Mean shift constituted the
mean absolute microsatellite length change per specimen in all
informative specimens at each locus. Monomorphic, quasi-
monomorphic, and polymorphic loci were defined as loci whose
mean shift (bases/specimen) was equal to 0, greater than 0 but less
than 1, and equal to 1 or greater, respectively, as described
previously [12]. Variants present in normal tissues were excluded
from the calculation of somatic %MSI and mean shift for tumors.
Statistic: regression analysis assessing the dependency of
%MSI upon microsatellite length
For this regression analysis, only data on 8- to 11-mer 39UTR
microsatellites were used as input: 12 to 14-mers were excluded
because only single-locus data was available for each length. Based
upon a meta-analysis of coding and noncoding microsatellites in
MSI-H CRCs, the correlation between %MSI and microsatellite
length followed a two-stage or sigmoid pattern: %MSI increased
quasi-exponentially in the short microsatellite length range, then
formed a plateau when %MSI approached 100% [20]. Based upon
a previous study of 15- to 28-mer 39UTR microsatellites that were
stable in the germline, mean shift in MSI-H CRCs was estimated to
reach 1 when microsatellite length was between 13 and 14 bases
[12]. Our data on 8- to 11-mer microsatellites was concluded to
represent mutational profiles in the quasi-exponential stage.
Therefore, we employed the following exponential growth model
for estimating the dependency of %MSI on microsatellite length:
m~czexp b0zb1   l ðÞ
where m and l are expected %MSI and microsatellite length,
respectively, while c, b0,a n db1 are parameters. Estimation of the
optimal parameter values to fit the actual data was conducted based
upon the Levenberg–Marquardt algorithm [21]. In calculating the
optimal parameter values, we also assumed that mutational
prevalence was 0 when microsatellite length was 1. As a measure
of the goodness of fit of the resulting model, the correlation
coefficient between observed and expected values was calculated for
the microsatellite length range in which this model could be
adequately representative (i.e., the range where expected mutation
prevalence did not reach 100%). Based upon this regression model,
95% confidence interval and 99% prediction interval were
calculated for the expected %MSIaccording to microsatellite length.
Prediction of mRNA secondary structure
RNA secondary structure and free energy for the wild type and
the dominant mutant at each locus were calculated by utilizing
pknotsRG-enf script [22]. RNA sequences containing the
microsatellite and 200 bases of its 59 and 39 flanking regions were
used as input.
39-UTR MSI in Colon Tumors
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Total RNA extraction, genomic DNA degradation, and random
hexamer-based cDNA synthesis for five normal colonic mucosae and
eight MSI-H primary CRCs were performed using an RNeasy kit
(Qiagen) and SuperScript III reverse transcriptase (Invitrogen). Real-
time quantitative RT-PCR assays were performed on an iQ5 PCR
machine (Bio-Rad) using iQ SYBR Green Supermix (Bio-Rad)
according to the manufacturer’s protocol. Beta-actin was analyzed for
normalization of data, as described previously [23]. Lack of non-
specific PCR products was verified by melting curve analysis of all PCR
products. The RB1CC1 amplicon (annealing temperature 56 degrees
C) used primer sequences 59-TGACAATATACTTCACTGGT-39
(forward) and 59-GCAATTAATATGGCTCATCA-39 (reverse), and
the beta-actin amplicon (annealing temperature 60 degrees C) used
primer sequences 59-ACCATGGATGATGATATCGCC-39 (for-
ward) and 59-GCCTTGCACATGCCGG-39 (reverse).
Results
Somatic and germline MSI profiles for 42 microsatellites (8 to
14-mers) located within 39UTRs were assessed in 45 primary MSI-
H colorectal tumors and their corresponding normal colonic
mucosae obtained from 44 patients, respectively. These 44 cases
consisted of 35 sporadic CRC patients and nine HNPCC patients;
one HNPCC subject had two synchronous CRCs. MSI prevalence
at each 39UTR locus was correlated with microsatellite length,
distance from stop codon and polyA site, and local interspecies
conservation level to determine factors that could control
instability of 39UTR microsatellites.
39UTR microsatellites are stable in germline cells
In order to determine variability at each locus in MMR-
proficient cells, we analyzed germline length polymorphisms of the
42 39UTR microsatellites in normal colonic tissues obtained from
the 44 MSI-H colorectal tumor patients. All 42 microsatellites
were stable: 35 loci were monomorphic, while seven loci (one of
thirteen 8-mers, two of twelve 9-mers, and three of eleven 10-mers)
were quasi-monomorphic (Figure 1). The prevalence of stable
(i.e., monomorphic and quasi-monomorphic) loci in our 8- to 14-
Table 1. Case demographic data.
Category All (n=45) HNPCC (n=10) Sporadic (n=35) p-value (test)
Gender
M 17 5 12 0.47 (Fisher’s exact test)
F2 8 5 2 3
Age
mean (*SD) 65.9 (13.0) 48.3 (10.5) 70.9 (8.5) 1.1610
28 (Student’s t-test)
Duke’s stage
A 4 0 4 0.029 (Kruskal-Wallis test)
B2 8 6 2 2
C8 1 7
D2 1 1
unknown 3 2 1
Differentiation
well 2 0 2 0.029 (Kruskal-Wallis test)
moderate 15 3 12
poor 15 3 12
unknown 13 4 9
Location
L 6 2 4 0.60 (Fisher’s exact test)
R3 9 8 3 1
All cases were Caucasian. HNPCC patients included one adenoma. P-values were calculated for the comparison of tumors from HNPCC patients versus sporadic cases.
*SD: standard deviation.
doi:10.1371/journal.pone.0007715.t001
Figure 1. Germline instability profile of the 42 39UTR micro-
satellites vs. microsatellite length. This scatterplot shows the
averaged change in microsatellite length (mean base shift, Y-axis)i n
normal colonic tissues of the 45 MSI-H colorectal tumor patients for
each of the 42 microsatellite loci and its association with microsatellite
length (X-axis). Each datapoint represents a 39UTR microsatellite. There
was no significant correlation between microsatellite length and mean
base shift.
doi:10.1371/journal.pone.0007715.g001
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the reported prevalence in longer microsatellite groups: eight (80%)
of ten loci in a 15- to 20-mer group (Fisher’s exact test p-value 0.03),
and five (29.4%) of 17 loci in the 21- to 32-mer group (Fisher’s exact
test p-value,5.0610
29) [12]. Nosignificant correlation wasdetected
between mean shift and interspecies sequence conservation level or
distance from stop codon or polyA signal for each microsatellite
(|r|,0.1). All seven quasi-monomorphic loci possessed only one
type of variant consisting of one-base insertion or deletion. Mean
shifts for these quasi-monomorphic loci were less than 0.1except for
one locus: NUAK family SNF1-like kinase 1 (NUAK1; mean shift 0.75).
Prevalence of germline variants for these seven monomorphic loci
was not significantly different between sporadic CRC and HNPCC
patients (Table S2).
3UTR microsatellite mutation status in MSI-H tumors is
dependent on microsatellite length
Somatic mutation status of the 42 39UTR microsatellites was
analyzed in all 45 primary MSI-H colorectal tumors (35 sporadic
CRCs, nine HNPCC-CRCs, and one HNPCC-associated adeno-
ma). Variants observed in germline cells were treated as wild-type.
Eight loci were not mutated in any of the 45 tumors, while 34 loci
showed varying mutation rates up to 68.4%. We then correlated
this somatic mutational profile with microsatellite attributes.
Similarly to germline variation, somatic mutation frequency did
not correlate significantly with local interspecies conservation level
or distance from stop codon or polyA site (|r|,0.1). However,
somatic mutation prevalence did correlate significantly with
microsatellite length. A regression analysis revealed that the
%MSI fit an exponential growth curve dependent on microsat-
ellite length (r=0.86 and p=7.2610
213; Figure 2). The %MSI
fit curve exceeded 100% at a microsatellite length of 13 bases,
which was consistent with previously published data on longer
39UTR microsatellites [12]. Additionally, somatic mutation
frequency was significantly higher in loci with flanking putative
miR binding sites than in those without flanking miR binding sites
(21.8% vs. 8.7%; t-test p-value 0.02). However, loci with flanking
miR binding sites tended to be longer than loci without flanking
miR binding sites (9.9 bases vs. 9.1 bases; t-test p-value 0.15). No
significant difference in mutation rate depending upon the
presence of flanking putative miR binding sites was observed
when loci of the same length were compared.
Three loci in our group demonstrated exceptionally high %MSI
in MSI-H colorectal tumors that exceeded the 99% prediction
limit for expected %MSI according to their lengths (Figure 2,
Table 2, and Table S1). The T11 repeat in the RB1-inducible
coiled-coil 1(RB1CC1) gene exhibited one- or two-base deletions in
26 (68.4%) of 38 informative cases, even though its corresponding
upper 99% prediction limit was only 40.2%. Similarly, the A10
repeat in the NUAK1 gene exhibited one- or two-base deletions in
13 (31.0%) of 42 cases. Furthermore, the T10 repeat in the Rtf1,
Paf1/RNA polymerase II complex component, homolog (RTF1) gene
exhibited one-base deletions or insertions in ten (25.0%) of 40
cases. The corresponding upper 99% prediction limit of these two
repeats was 24.0%. Notably, RB1CC1 biallelic mutation was
significantly infrequent (two of 38 cases, 5.3%) relative to the
expected frequency based upon mutant allele incidence (13.6%,
five of 38 cases; Fisher’s exact test p value, 0.01). Biallelic mutation
in NUAK1 (two of 42, 4.8%) and RTF1 (zero of 41, 0%) did not
significantly differ in prevalence from their expected frequencies
(3.2% and 1.6% for NUAK1 and RTF1, respectively). No
statistically significant association was observed between the
presence of these mutations and background disease, anatomical
site within the colon, clinical stage, or degree of histological
differentiation for the informative tumors (Table S3).
In order to make a preliminary assessment of the potential
functional impact of 39UTR MSI, we analyzed the predicted RNA
secondary structure and free energy for the wild type and the most
common mutant of the T11 repeat in RB1CC1, the A10 repeat in
NUAK1, and the T10 repeat in RTF1 (Table 2). The most
common RB1CC1 mutant, T10, greatly altered its predicted
39UTR RNA secondary structure (Figure 3). This predicted
RB1CC1 structural change affected putative miR-133 and miR-
138 binding sites flanking the microsatellite, and the miR-138
binding site structure demonstrated the greatest change caused by
the mutation. The RB1CC1 mutant lost a large loop structure that
covered the majority of both 59 seed and 39 complementary sites
that had existed in the wild-type RNA. Interestingly, we observed
significant RB1CC1 mRNA overexpression in primary MSI-H
CRCs carrying RB1CC1 mutant alleles relative to normal colonic
mucosae (mean fold-change 9.0, p=3.7610
24, Figure 4). The
most common RTF1 mutant, T9, altered both free energy and
predicted RNA structure (data not shown). However, the affected
RTF1 39UTR region was small (up to 50 bases 59 and 39 of the
microsatellite) and did not contain any putative 39UTR regulatory
motifs. Consequently, this mutation was unlikely to result in
sizable functional effects. The most common NUAK1 mutant, A9,
did not affect either RNA secondary structure or free energy.
Discussion
The current broad mutational profiling of 42 short (8–14 base)
39UTR microsatellites revealed that somatic microsatellite muta-
tion frequency in 45 MSI-H colon tumors correlated significantly
with microsatellite length, which was consistent to a previous
meta-analysis on coding and noncoding microsatellites [20]. The
overall mutation frequency was higher in this meta-analysis than
the current study. Mutation frequency in the meta-analysis might
have been high, in part, due to the publication bias against
Figure 2. Somatic mutational profile of the 42 39UTR micro-
satellites vs. microsatellite length. This scatterplot shows the
prevalence of mutated tumors at each microsatellite (Y-axis) for the 45
MSI-H colorectal tumors and its significant association with microsat-
ellite length (X-axis). Each datapoint represents a 39UTR microsatellite
locus. The blue line represents the fit curve calculated based upon non-
linear regression analysis: the r- and the p-values were 0.86 and
7.2610
213, respectively, for the correlation between observed and
expected mutation prevalence. Brown line and dotted black lines signify
95% confidence limits and 99% prediction limits, respectively.
doi:10.1371/journal.pone.0007715.g002
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edge-based subject locus selection in many reports, and absence of
consideration to germline polymorphism level in many reports.
Germline variation prevalence was not significantly dependent on
microsatellite length within our short microsatellite group;
however, a significant microsatellite length dependency of germ-
line variation prevalence was observed when our data were
compared to previously studied groups of longer (15–20 and 21–
28 base) 39UTR microsatellites [12]. In yeast, repeat number and
repeat unit size dictate the susceptibility to DNA strand slippage
and microsatellite instability [24,25]. Thus, our observations
confirm that susceptibility to DNA strand slippage is the
determinant of length polymorphism in the majority of 39UTR
microsatellites in both MMR-deficient and -proficient settings in
humans.
In the current study, we assessed interspecies sequence
conservation level and proximity to some genetic elements as
indicators of the potential relevance of a microsatellite to the
posttranscriptional functional integrity of the corresponding gene.
Interspecies sequence conservation level and proximity to other
genetic elements were not associated with microsatellite length
variation. The presence of flanking putative miR binding sites
initially appeared to be associated with higher somatic MSI rates.
This association became undetectable in comparisons of micro-
satellites of the same length, although the number of loci in each
comparison was limited. These observations indicate that
functional relevance of microsatellite is not the major determinant
of length polymorphism in both MMR-deficient and -proficient
settings in human.
An exceptionally high incidence of tumors possessing mutations
in a gene suggests that cells containing these mutations were
subjected to clonal expansion in multiple individuals due to certain
selective advantages provided by these mutations during multi-step
carcinogenesis [26]. In the current study, we identified three
39UTR microsatellite loci that demonstrated high mutation rates
in primary MSI-H colorectal tumors, even when this microsatellite
length-dependent mutability in MMR-deficient cells was taken
into account. These loci included the T11 repeat in the multi-
functional gene, RB1CC1 (also known as FIP200), the A10 repeat in
the pro-survival and anti-apoptotic serine-threonine kinase gene,
NUAK1, and the T10 repeat in the PAF1-complex subunit gene,
RTF1, that is essential to histone methylation and Notch signaling
[27,28,29]. Mutations in these microsatellites did not correlate
significantly with clinical attributes of the tumors in our analysis.
However, the relatively limited sample size in some tumor
subgroups, may have limited detectable differences.
Of the three prevalent 39UTR MSIs, RB1CC1 mutation was the
most likely to be functionally relevant for three reasons: 1) the
observed RB1CC1 somatic mutation rate exceeded the microsat-
ellite length-based 99% prediction limit by the largest magnitude
(1.7-fold), 2) significant RB1CC1 mRNA overexpression was
observed in primary MSI-H CRCs relative to nonneoplastic
colonic mucosae, and 3) RB1CC1 39UTR MSI was predicted to
alter the secondary structure of putative binding sites for miRs-133
and -138. One of miR functions is promotion of mRNA decay by
directing polyA tail removal via incomplete complementary
binding to mRNA [30]. Kertesz et al. showed that changes in
target mRNA secondary structure reduced miR effects, when the
change was loss of loop structures within miR binding sites [31].
The RB1CC1 39UTR microsatellite mutant was predicted to lose a
large loop structure within its putative miR-138 binding site,
making disruption of the miR-138-RB1CC1 interaction and
subsequent posttranscriptional downregulation likely in the
mutant. The observed RB1CC1 mRNA upregulation in RB1CC1
mutant MSI-H CRCs is consistent with this hypothesis. Further
direct assessments are needed to investigate this potential scenario.
RB1CC1 plays complex roles in cellular pathways relevant to
carcinogenesis [27]. RB1CC1 acts oncogenic in promoting cell
survival and migration by activating Wnt signaling, TNF-alpha-
induced JNK activity, and mTOR signaling in vitro and in vivo
[32,33]. RB1CC1 acts tumor suppressive in inhibiting cell cycle
progression and proliferation by RB1 induction, p53 stabilization,
Table 2. Locus description and somatic mutational properties of three highly mutable 39UTR microsatellites.
Category RB1CC1 NUAK1 RTF1
Repeat T11 A10 T10
Locus 8q11 12q23.3 15q15.1
Distance from stop codon (bases) 219 1964 2131
Distance from polyA signal (bases) 970 1471 741
*PhastCons score: mean (SD) 0.21 (0.22) 0.67 (0.32) 0.00 (0.00)
**Flanking miR binding sites miR-138, miR-133 2 miR-26, miR-139
***Flanking ARE motifs ++ 2
Total informative tumors (%) 38 (100.0) 42 (100.0) 40 (100.0)
Mutant tumors (%) 26 (68.4) 13 (31.0) 10 (25.0)
Wild type tumors (%) 12 (31.6) 29 (69.0) 30 (75.0)
Major mutant T10 A9 T9
%D free energy of the major mutant 0 0 20.1
Structure change of the major mutant + 2 +
Locus information and overall mutation prevalence describes the genetic attributes and mutation status in MSI-H colon tumors for microsatellites located within the
39UTRs of RB1CC1, NUAK1,a n dRTF1.
*PhastCons score: Mean and standard deviation of basewise microsatellite sequence conservation score among 31 placental mammals. The value closer to 1 indicates a
high conservation level, and a large standard deviation indicates a change in conservation pattern within the microsatellite.
**Flanking miR binding sites: Putative miR binding sites predicted by TargetScan and miRanda scripts within 200 bases of the 39 or 59 flanking regions of the
corresponding microsatellite.
***Flanking ARE motifs: presence of AU-rich elements within the 39UTR, according to the Integrated ARED database.
doi:10.1371/journal.pone.0007715.t002
39-UTR MSI in Colon Tumors
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STAT protein inhibition in vitro [34,35,36,37,38]. Despite the
frequent RB1CC1 deletion in primary human breast cancers,
RB1CC1 conditional knockout in mamillary gland and skin failed
to promote tumorigenesis [39,40]. These reports indicate that the
impact of RB1CC1 upon tumorigenesis differs depending upon
context. The mRNA upregulation and relative rarity of RB1CC1
biallelic mutation observed in MSI-H colorectal tumors appears to
support potential oncogenic roles of RB1CC1 in the colon.
Consistent to this notion, the RB1CC1 locus (8q11.23) is frequently
amplified in CRCs [41]. A putative RB1CC1-targeting micro-
RNA, miR-138, is a tumor-suppressor miR and downregulated in
non-colonic malignancies [42,43]. Taken together, it is speculated
that RB1CC1 may act as an oncogene in large intestine, and that
39UTR MSI may serve as an upregulatory mechanism in place of
genomic amplification in MSI-H cancers that typically lack
chromosomal aberrations.
In summary, we verified the strong dependency of MSI
incidence upon microsatellite length in MSI-H colorectal tumors
and, to a lesser degree, in MMR-proficient cells by conducting an
extensive survey of well-characterized short 39UTR microsatel-
lites. In contrast, relevance of a microsatellite to its corresponding
Figure 3. The impact of MSI upon 39UTR mRNA secondary structure of the RB1CC1 gene. This drawing illustrates the difference in
predicted secondary mRNA structure of the RB1CC1 39UTR containing putative microRNAs binding sites between wild type (T11) and the most
prevalent microsatellite mutant (T10) observed in the MSI-H colorectal tumors. A black line represents the microsatellite. Dots represent putative
microRNA binding sites (the 39-complementary site is highlighted in red). Secondary structure was altered for both the miR-133-a/b and miR-138
binding sites in the T10 mutant. The miR-138 binding site structure demonstrated the greatest change caused by the microsatellite mutation: the
mutant lost a large loop structure that covered the majority of both 59 seed and 39 complementary sites that had existed in the wild-type.
doi:10.1371/journal.pone.0007715.g003
Figure 4. RB1CC1 mRNA overexpression in primary MSI-H colon
cancers.QuantitativeRT-PCRdataforRB1CC1areshownineightnormal
colonic mucosae (NMs) and five primary MSI-H CRCs (PTs). A ratio to the
average of 8NMs is shown as the value representing the beta-actin-
normalized RB1CC1 mRNA expression in each sample. RB1CC1 was
significantly overexpressed in primary MSI-H CRCs relative to normal
colonic mucosae (mean fold-change 9.0, p=3.7610
24) base deletion.
doi:10.1371/journal.pone.0007715.g004
39-UTR MSI in Colon Tumors
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incidence. We also established a lack of correlation between MSI
incidence and sequence conservation level or distance from genetic
elements. Our data indicate that microsatellite length dependency
should be taken into account when evaluating 39UTR MSI in
MMR-deficient cells. This study also provides a screening strategy
for novel functionally relevant 39UTR MSI events in human
tumorigenesis. This screening identified frequent mutation and
aberrant mRNA upregulation of RB1CC1 in MSI-H colorectal
tumors, which deserves further investigation of its potential
involvement in colorectal tumorigenesis.
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